Greenstone, Eisai to launch authorized generic of Aricept
PEAPACK, N.J. The generics division of Pfizer will sell an authorized generic version of a drug used to treat dementia.
Greenstone said Wednesday that it had agreed with Eisai to launch donepezil hydrochloride tablets, an authorized generic of Aricept. The drug is used to treat dementia related to Alzheimer’s disease. Eisai makes the drug under a partnership with Pfizer.
“We are excited about the opportunity to work with Eisai to introduce this important authorized generic to patients,” said James Cannon, Greenstone’s VP business alliances. “First and foremost, our goal is to provide donepezil hydrochloride tablets to the broad customer base, and we also strive to remain competitive with other potential generic versions of the product.”
Unlike generic drugs, which are marketed in competition with their branded counterparts and must undergo an abbreviated regulatory approval process through the Food and Drug Administration, authorized generics are essentially branded drugs marketed under their generic names with the authorization of the original drug’s manufacturer and often through third-party companies.
Wallace named GSK Consumer Healthcare VP
PITTSBURGH GlaxoSmithKline Consumer Healthcare on Tuesday named Stacy Wallace to the newly created role of VP customer marketing and 360° Insights.
Under Wallace’s direction, the customer marketing and 360° Insights team will continue the development and execution of category visions and strategies in the area of health and wellness and in the creation of insight-led innovative and fully evaluated shopper marketing programs, the company stated.
Wallace joined GSK in 2002 working in the United Kingdom on the nutritional healthcare business. She joined the GSK Consumer Healthcare U.S. business in 2008 as the sales strategy director and most recently served as director of category marketing and 360° Insights.
Wallace was recently profiled in the “Who’s Who in Shopper Marketing,” a publication that recognizes the best in the industry in insight-driven, customized retail shopper marketing activation.
FDA to investigate egg production sites
SILVER SPRING, Md. Investigators at the Food and Drug Administration will check the 600 largest egg production facilities in the United States over the next 15 months, with the help of state and local partners.
The FDA’s efforts are part of a new egg safety rule that went into effect in July, following a salmonella outbreak. Nearly 1,500 cases of illnesses were reported, according to FDA Consumer Health Information.
The announcement was posted on the agency’s website.